ey0020.2-11 | Long-Acting Growth Hormone (LAGH) | ESPEYB20
A Juul , P Backeljauw , M Hojby , M Kawai , RJ Kildemoes , A Linglart , N Zuckerman-Levin , R Horikawa
ey0020.3-10 | Advances in Clinical Practice | ESPEYB20
G Del Sindaco , J Berkenou , A Pagnano , A Rothenbuhler , M Arosio , G Mantovani , A Linglart
ey0020.3-11 | Advances in Clinical Practice | ESPEYB20
W Hogler , A Linglart , A Petryk , PS Kishnani , L Seefried , S Fang , C Rockman-Greenberg , K Ozono , K Dahir , GA Martos-Moreno
ey0015.5-1 | New and repurposed therapies | ESPEYB15
TO Carpenter , MP Whyte , EA Imel , AM Boot , W Hogler , A Linglart , R Padidela , W Van't Hoff , M Mao , CY Chen , A Skrinar , E Kakkis , J San Martin , AA Portale
ey0019.14-14 | New treatments | ESPEYB19
Zhukouskaya Volha V , Jauze Louisa , Charles Severine , Leborgne Christian , Hilliquin Stephane , Sadoine Jeremy , Slimani Lotfi , Baroukh Brigitte , van Wittenberghe Laetitia , Daniele Natalie , Rajas Fabienne , Linglart Agnes , Mingozzi Federico , Chaussain Catherine , Bardet Claire , Ronzitti Giuseppe
ey0016.5-12 | Clinical Guidance | ESPEYB16
D Haffner , F Emma , DM Eastwood , MB Duplan , J Bacchetta , D Schnabel , P Wicart , D Bockenhauer , F Santos , E Levtchenko , P Harvengt , M Kirchhoff , F Di Rocco , C Chaussain , ML Brandi , L Savendahl , K Briot , P Kamenicky , L Rejnmark , A Linglart
ey0020.3-4 | Advances in Clinical Practice | ESPEYB20
MT Collins , G Marcucci , HJ Anders , G Beltrami , JA Cauley , PR Ebeling , R Kumar , A Linglart , L Sangiorgi , DA Towler , R Weston , MP Whyte , ML Brandi , B Clarke , RV Thakker
ey0020.2-2 | Important for Clinical Practice | ESPEYB20
M Maghnie , MB Ranke , ME Geffner , E Vlachopapadopoulou , L Ibanez , M Carlsson , W Cutfield , R Rooman , R Gomez , MP Wajnrajch , A Linglart , R Stawerska , PE Clayton , F Darendeliler , ACS Hokken-Koelega , R Horikawa , T Tanaka , HG Dorr , K Albertsson-Wikland , M Polak , A Grimberg